Lonza Group AG (OTCMKTS:LZAGY) Forecasted to Post FY2024 Earnings of $1.31 Per Share

Lonza Group AG (OTCMKTS:LZAGY - Free Report) - Investment analysts at William Blair lowered their FY2024 earnings per share estimates for Lonza Group in a research report issued to clients and investors on Tuesday, May 14th. William Blair analyst M. Smock now forecasts that the company will post earnings of $1.31 per share for the year, down from their previous forecast of $1.36. The consensus estimate for Lonza Group's current full-year earnings is $1.39 per share.

Separately, Deutsche Bank Aktiengesellschaft raised Lonza Group from a "hold" rating to a "buy" rating in a report on Friday, February 2nd.

Lonza Group Price Performance

LZAGY traded up $0.17 during midday trading on Friday, reaching $58.09. 26,433 shares of the company's stock traded hands, compared to its average volume of 137,200. The firm has a fifty day moving average of $57.31 and a two-hundred day moving average of $48.25. The company has a current ratio of 1.77, a quick ratio of 1.20 and a debt-to-equity ratio of 0.27. Lonza Group has a 52 week low of $34.19 and a 52 week high of $66.00.

Lonza Group Cuts Dividend

The firm also recently declared a dividend, which will be paid on Wednesday, May 29th. Shareholders of record on Thursday, May 16th will be paid a $0.0995 dividend. The ex-dividend date is Wednesday, May 15th.

About Lonza Group

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.